300 related articles for article (PubMed ID: 24385203)
1. Potential involvement of the IL-33-ST2 axis in the pathogenesis of primary Sjogren's syndrome.
Awada A; Nicaise C; Ena S; Schandéné L; Rasschaert J; Popescu I; Gangji V; Soyfoo MS
Ann Rheum Dis; 2014 Jun; 73(6):1259-63. PubMed ID: 24385203
[TBL] [Abstract][Full Text] [Related]
2. The Interleukin 33/ST2 axis in patients with primary Sjögren syndrome: expression in serum and salivary glands, and the clinical association.
Jung SM; Lee J; Baek SY; Lee JH; Lee J; Park KS; Park SH; Kim HY; Kwok SK
J Rheumatol; 2015 Feb; 42(2):264-71. PubMed ID: 25512474
[TBL] [Abstract][Full Text] [Related]
3. Potential contribution of interleukin-33 to the development of interstitial lung disease in patients with primary Sjogren's Syndrome.
Zhao L; Yao L; Yuan L; Xia L; Shen H; Lu J
Cytokine; 2013 Oct; 64(1):22-4. PubMed ID: 23910012
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-36α axis is modulated in patients with primary Sjögren's syndrome.
Ciccia F; Accardo-Palumbo A; Alessandro R; Alessandri C; Priori R; Guggino G; Raimondo S; Carubbi F; Valesini G; Giacomelli R; Rizzo A; Triolo G
Clin Exp Immunol; 2015 Aug; 181(2):230-8. PubMed ID: 25902739
[TBL] [Abstract][Full Text] [Related]
5. Invariant NKT cells are expanded in peripheral blood but are undetectable in salivary glands of patients with primary Sjögren's syndrome.
Guggino G; Ciccia F; Raimondo S; Giardina G; Alessandro R; Dieli F; Sireci G; Triolo G
Clin Exp Rheumatol; 2016; 34(1):25-31. PubMed ID: 26633038
[TBL] [Abstract][Full Text] [Related]
6. Phagocyte-specific S100A8/A9 is upregulated in primary Sjögren's syndrome and triggers the secretion of pro-inflammatory cytokines in vitro.
Nicaise C; Weichselbaum L; Schandene L; Gangji V; Dehavay F; Bouchat J; Balau B; Vogl T; Soyfoo MS
Clin Exp Rheumatol; 2017; 35(1):129-136. PubMed ID: 27749214
[TBL] [Abstract][Full Text] [Related]
7. Systemic and local interleukin-17 and linked cytokines associated with Sjögren's syndrome immunopathogenesis.
Katsifis GE; Rekka S; Moutsopoulos NM; Pillemer S; Wahl SM
Am J Pathol; 2009 Sep; 175(3):1167-77. PubMed ID: 19700754
[TBL] [Abstract][Full Text] [Related]
8. Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sjögren's syndrome.
Ciccia F; Guggino G; Rizzo A; Alessandro R; Carubbi F; Giardina A; Cipriani P; Ferrante A; Cannizzaro A; Giacomelli R; Triolo G
Rheumatology (Oxford); 2014 Jul; 53(7):1313-20. PubMed ID: 24602921
[TBL] [Abstract][Full Text] [Related]
9. Possible role for IL-40 and IL-40-producing cells in the lymphocytic infiltrated salivary glands of patients with primary Sjögren's syndrome.
Guggino G; Rizzo C; Mohammadnezhad L; Lo Pizzo M; Lentini VL; Di Liberto D; La Barbera L; Raimondo S; Shekarkar Azgomi M; Urzì O; Berardicurti O; Campisi G; Alessandro R; Giacomelli R; Dieli F; Ciccia F
RMD Open; 2023 May; 9(2):. PubMed ID: 37137540
[TBL] [Abstract][Full Text] [Related]
10. Salivary cytokine profiles in primary Sjögren's syndrome differ from those in non-Sjögren sicca in terms of TNF-α levels and Th-1/Th-2 ratios.
Kang EH; Lee YJ; Hyon JY; Yun PY; Song YW
Clin Exp Rheumatol; 2011; 29(6):970-6. PubMed ID: 22132900
[TBL] [Abstract][Full Text] [Related]
11. Role of fractalkine in the pathogenesis of primary Sjögren syndrome: increased serum levels of fractalkine, its expression in labial salivary glands, and the association with clinical manifestations.
Lee JH; Kwok SK; Jung SM; Lee J; Lee JS; Baek SY; Kim EK; Ju JH; Park SH; Kim HY
J Rheumatol; 2014 Dec; 41(12):2425-38. PubMed ID: 25320221
[TBL] [Abstract][Full Text] [Related]
12. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome.
Ittah M; Miceli-Richard C; Eric Gottenberg J; Lavie F; Lazure T; Ba N; Sellam J; Lepajolec C; Mariette X
Arthritis Res Ther; 2006; 8(2):R51. PubMed ID: 16507175
[TBL] [Abstract][Full Text] [Related]
13. IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren's syndrome and is associated with the local expansion of pro-inflammatory CD14(bright)CD16+ monocytes.
Ciccia F; Alessandro R; Rodolico V; Guggino G; Raimondo S; Guarnotta C; Giardina A; Sireci G; Campisi G; De Leo G; Triolo G
Rheumatology (Oxford); 2013 Jun; 52(6):1009-17. PubMed ID: 23392590
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of follicular helper T cells by salivary gland epithelial cells in primary Sjögren's syndrome.
Gong YZ; Nititham J; Taylor K; Miceli-Richard C; Sordet C; Wachsmann D; Bahram S; Georgel P; Criswell LA; Sibilia J; Mariette X; Alsaleh G; Gottenberg JE
J Autoimmun; 2014 Jun; 51():57-66. PubMed ID: 24411167
[TBL] [Abstract][Full Text] [Related]
15. IL-2 Inhibition of Th17 Generation Rather Than Induction of Treg Cells Is Impaired in Primary Sjögren's Syndrome Patients.
Luo J; Ming B; Zhang C; Deng X; Li P; Wei Z; Xia Y; Jiang K; Ye H; Ma W; Liu Z; Li H; Yang XP; Dong L
Front Immunol; 2018; 9():1755. PubMed ID: 30150979
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiologic role of Interleukin-33/ST2 in Sjögren's syndrome.
Soyfoo MS; Nicaise C
Autoimmun Rev; 2021 Mar; 20(3):102756. PubMed ID: 33476812
[TBL] [Abstract][Full Text] [Related]
17. Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren's syndrome.
Ciccia F; Guggino G; Rizzo A; Ferrante A; Raimondo S; Giardina A; Dieli F; Campisi G; Alessandro R; Triolo G
Ann Rheum Dis; 2012 Feb; 71(2):295-301. PubMed ID: 21979002
[TBL] [Abstract][Full Text] [Related]
18. TLR2 ligation induces the production of IL-23/IL-17 via IL-6, STAT3 and NF-kB pathway in patients with primary Sjogren's syndrome.
Kwok SK; Cho ML; Her YM; Oh HJ; Park MK; Lee SY; Woo YJ; Ju JH; Park KS; Kim HY; Park SH
Arthritis Res Ther; 2012 Mar; 14(2):R64. PubMed ID: 22417709
[TBL] [Abstract][Full Text] [Related]
19. Increased interleukin (IL)-7Rα expression in salivary glands of patients with primary Sjogren's syndrome is restricted to T cells and correlates with IL-7 expression, lymphocyte numbers and activity.
Bikker A; Kruize AA; Wenting M; Versnel MA; Bijlsma JW; Lafeber FP; van Roon JA
Ann Rheum Dis; 2012 Jun; 71(6):1027-33. PubMed ID: 22312161
[TBL] [Abstract][Full Text] [Related]
20. The IL33/ST2 axis in Sjogren syndrome in relation to disease activity.
Margiotta DP; Navarini L; Vadacca M; Lo Vullo M; Pignataro F; Basta F; Afeltra A
Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1295-9. PubMed ID: 27097949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]